Publications

Affichage de 1601 à 1610 sur 16055


  • COMM

Glass-to-glass delay reduction: encoding rate reduction vs. video frame extrapolation

Hind Kanj, Anthony Trioux, Marco Cagnazzo, François-Xavier Coudoux, Patrick Corlay, M. Kieffer

Applications such as teleoperated driving, remote robot control, and telepresence rely on video services to ensure real-time interaction with a satisfying quality of experience. Reducing the Glass-to-Glass (G2G) delay, i.e., the time delay between the acquisition of a video frame and its display on…

2023 IEEE 25th International Workshop on Multimedia Signal Processing, MMSP, IEEE, Sep 2023, Poitier, France. pp.1-6, ⟨10.1109/MMSP59012.2023.10337718⟩. ⟨hal-04246725⟩

  • ART

Mid-wave Infrared sensitized InGaAs using Intraband Transition in Doped Colloidal II-VI Nanocrystals

Adrien Khalili, Mariarosa Cavallo, Tung Huu Dang, Corentin Dabard, Huichen Zhang, Erwan Bossavit, Claire Abadie, Yoann Prado, Xiang Zhen Xu, Sandrine Ithurria, Grégory Vincent, Christophe Coinon, Ludovic Desplanque, Emmanuel Lhuillier

Narrow bandgap nanocrystals (NCs) are now used as infrared light absorbers, making them competitors to epitaxially grown semiconductors. However, these two types of material could benefit from one another. While bulk materials are more effective in transporting carriers and give a high degree of…

The Journal of Chemical Physics, 2023, 158 (9), pp.094702. ⟨10.1063/5.0141328⟩. ⟨hal-04009888⟩

  • ART

Evaluation of Strategies for Reducing Vancomycin-Piperacillin/Tazobactam Incompatibility

Anthony Martin Mena, Laura Négrier, A. Treizebre, Marie Guilbert, Lucille Bonnaire, Valentine Daniau, Gabie Leba Bonki, Pascal Odou, Stéphanie Genay, Bertrand Décaudin

Background: Drug incompatibility is defined as a physical-chemical reaction between two or more injectable drugs and that results mainly in precipitation or insolubility. Several strategies for reducing incompatibilities have been implemented empirically in intensive care units. However, these…

Pharmaceutics, 2023, Advances in Parenteral Formulations, 15 (8), pp.2069. ⟨10.3390/pharmaceutics15082069⟩. ⟨hal-04196721⟩